Statistics
Publications
2
Citations
1.5K
H-Index
2
Active since
2007
Affiliations
Boehringer Ingelheim (Austria)(Current)
D Li is an author at Boehringer Ingelheim (Austria) specializing in oncology, medicine, and molecular oncology.
Publications per year
2007–2008
2
2
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
D Li, Lauren Ambrogio, Takeshi Shimamura et al. · Oncogene · 2008 · 1.4K citations · Full text
Medicine, Oncology, Pharmacology +11
1–2 of 2